Study on Chemotherapy and Radiation Therapy Followed by Chemotherapy for Localized Esophageal Cancer

Inclusion Criteria

• Must be able to give informed consent to participate in the study.
• Newly diagnosed with adenocarcinoma of the thoracic esophagus or gastroesophageal junction.
• Cancer stage II to IVA, but not T4b, according to specific medical guidelines.
• Complete medical history and physical exam within 21 days before joining the study.
• Recent whole-body scan to confirm no spread of cancer, done within 45 days before joining.
• Good overall health with an ECOG performance status of 0 to 2.
• Suitable for planned chemotherapy and radiation treatment as determined by medical specialists.
• Adequate blood, kidney, and liver function within 14 days before starting treatment.

Exclusion Criteria

• Cancer located in the cervical esophagus.
• Esophageal squamous cell carcinoma.
• Cancer stage T4b according to specific medical guidelines.
• Evidence of cancer spread to other parts of the body.
• Previous chemotherapy or radiation for the current cancer diagnosis.
• Previous chest radiation that would overlap with current treatment areas.
• Another progressing cancer that needs treatment, except for certain skin cancers or in situ cervical cancer.
• Severe active health issues, such as uncontrolled infections needing IV antibiotics.
• Pregnant or breastfeeding women.
• HIV positive with a low CD4 count, unless under treatment and with a stable CD4 count.
• Any physical or psychological issues that would prevent participation, as judged by the doctor.
• Known psychiatric or substance abuse issues that would interfere with the study.